Search Results - Rouffiac, Elisabeth

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    The efficacy and safety of oral pharmacokinetically enhanced amoxycillin–clavulanate 2000/125 mg, twice daily, versus oral amoxycillin–clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults

    The efficacy and safety of oral pharmacokinetically enhanced amoxycillin–clavulanate 2000/125 mg, twice daily, versus oral amoxycillin–clavulanate 1000/125 mg, three times daily, f... by Petitpretz, Patrick, Chidiac, Christian, Soriano, Francisco, Garau, Javier, Stevenson, Katharine, Rouffiac, Elisabeth

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    The efficacy and safety of oral pharmacokinetically enhanced amoxycillin-clavulanate 2000/125 mg, twice daily, versus oral amoxycillin-clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults: Resistant pneumococci

    The efficacy and safety of oral pharmacokinetically enhanced amoxycillin-clavulanate 2000/125 mg, twice daily, versus oral amoxycillin-clavulanate 1000/125 mg, three times daily, f... by PETITPRETZ, Patrick, CHIDIAC, Christian, SORIANO, Francisco, GARAU, Javier, STEVENSON, Katharine, ROUFFIAC, Elisabeth

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: